AstraZeneca Rumored to Bid €176 Per Share for French Biotech Abivax Amid M&A Buzz

Abivax shares jump 6% on reports of AstraZeneca's €176-per-share offer for the French inflammatory disease drugmaker, adding to ongoing acquisition speculation.